The Kensey Nash Cartilage Repair Device is a biphasic, bioresorbable scaffold intended to be implanted at the site of a focal articular cartilage lesion or osteochondral defect in the knee and intended to serve as a scaffold for cellular and matrix in-growth in osteochondral defect repair such as bone and/or cartilage, according to the release. The product is indicated to support the regeneration of hyaline cartilage and subchondral bone by promoting the correct cellular morphology and structural organization during the healing process.
Articular cartilage injury is commonly encountered in people with active lifestyles, and unlike other tissue types, cartilage possesses a limited capacity to heal, according to the release. Surgical treatment options available today usually generate a repair tissue that is insufficient in absorbing or distributing loads and is prone to failure, and debilitating osteoarthritis may develop in the afflicted joint, often ultimately requiring partial or total knee replacement. Kensey Nash said in the release that it believes an early and successful treatment of traumatized articular cartilage may prevent or postpone the onset of long-term osteoarthritis and consequently reduce the number of radical knee joint replacement surgeries performed each year.
Read the release on the Kensey Nash Cartilage Repair Device.
